Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

Affiliations

Free article

Comment

John B Buse et al. N Engl J Med. 2016.

Free article

. 2016 Nov 3;375(18):1798-9.

doi: 10.1056/NEJMc1611289.

No abstract available

Comment on

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB; LEADER Steering Committee; LEADER Trial Investigators. Marso SP, et al. N Engl J Med. 2016 Jul 28;375(4):311-22. doi: 10.1056/NEJMoa1603827. Epub 2016 Jun 13. N Engl J Med. 2016. PMID: 27295427 Free PMC article. Clinical Trial.
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Cohen S, Beckey C. Cohen S, et al. N Engl J Med. 2016 Nov 3;375(18):1797. doi: 10.1056/NEJMc1611289. N Engl J Med. 2016. PMID: 27806226 No abstract available.
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Correia LC, Latado A, Porzsolt F. Correia LC, et al. N Engl J Med. 2016 Nov 3;375(18):1798. doi: 10.1056/NEJMc1611289. N Engl J Med. 2016. PMID: 27806227 No abstract available.
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Álvarez-Villalobos NA, Treviño-Alvarez AM, González-González JG. Álvarez-Villalobos NA, et al. N Engl J Med. 2016 Nov 3;375(18):1797-8. doi: 10.1056/NEJMc1611289. N Engl J Med. 2016. PMID: 28106973 No abstract available.